Normocalcemic primary hyperparathyroidism: Evidence for a generalized target-tissue resistance to parathyroid hormone

被引:139
作者
Maruani, G [1 ]
Hertig, A [1 ]
Paillard, M [1 ]
Houillier, P [1 ]
机构
[1] Univ Paris 06, Hop Europeen Georges Pomidou,Dept Physiol, Assistance Publ Hop Paris,INSERM,U356, Inst Federat Rech 58, F-75015 Paris, France
关键词
D O I
10.1210/jc.2002-021404
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Primary hyperparathyroidism (PHPT) is usually characterized by fasting hypercalcemia associated with inappropriately high PTH concentration. Nevertheless, cases of proven PHPT have been reported in normocalcemic patients. The purpose of the study was to investigate the mechanism(s) of persistent normocalcemia in PHPT. One hundred seventy-eight patients with PHPT were studied after exclusion of any evident cause of masked hypercalcemia. Patients were separated into normocalcemic (n = 34) and hypercalcemic (n = 144) subgroups on the basis of their fasting serum ionized calcium value. Patients with normocalcemic PHPT had, on average, a milder excess in PTH secretion assessed by a lower serum PTH concentration. Because of a clear overlap in PTH values between the two groups, normocalcemic and hypercalcemic patients were matched on the basis of serum PTH concentration, age, and sex. Patients with normocalcemic PHPT had lower fasting urine calcium excretion and renal tubular calcium reabsorption. In addition, normocalcemic patients differed from hypercalcemic patients by lower values of markers of bone turnover and plasma 1,25 dihydroxyvitamin D and higher values of renal phosphate threshold. In conclusion, a significant proportion of patients with PHPT are truly normocalcemic, and in addition to a milder increase in PTH secretion, the normocalcemic patients appear to display resistance to PTH action on bone and kidney.
引用
收藏
页码:4641 / 4648
页数:8
相关论文
共 37 条
[11]  
GALLAGHER JC, 1972, LANCET, V1, P503
[12]   Development of a novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone 1-84: Implications for improvement of accurate assessment of parathyroid function [J].
Gao, P ;
Scheibel, S ;
D'Amour, P ;
John, MR ;
Rao, SD ;
Schmidt-Gayk, H ;
Cantor, TL .
JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 (04) :605-614
[13]  
GARDIN JP, 1984, MINER ELECTROL METAB, V10, P301
[14]   EXPERIMENTAL HYPERPARATHYROIDISM FROM MULTIPLE ISOLOGOUS PARATHYROID TRANSPLANTS - HOMEOSTATIC EFFECT OF SIMULTANEOUS THYROID TRANSPLANTS [J].
GITTES, RF ;
RADDE, IC .
ENDOCRINOLOGY, 1966, 78 (05) :1015-+
[15]   Calciuric response to an acute acid load in healthy subjects and hypercalciuric calcium stone formers [J].
Houillier, P ;
Normand, M ;
Froissart, M ;
Blanchard, A ;
Jungers, P ;
Paillard, M .
KIDNEY INTERNATIONAL, 1996, 50 (03) :987-997
[16]  
KUROKAWA K, 1994, KIDNEY INT, V45, pS97
[17]   Population-based screening for primary hyperparathyroidism with serum calcium and parathyroid hormone values in menopausal women [J].
Lundgren, E ;
Rastad, J ;
Thurfjell, E ;
Akerstrom, G ;
Ljunghall, S .
SURGERY, 1997, 121 (03) :287-294
[18]   Parathyroid tissue in normocalcemic and hypercalcemic primary hyperparathyroidism recruited by health screening [J].
Lundgren, E ;
Ridefelt, P ;
Akerstrom, G ;
Ljunghall, S ;
Rastad, J .
WORLD JOURNAL OF SURGERY, 1996, 20 (07) :727-735
[19]   CONJUGATED ESTROGENS IN THE TREATMENT OF POSTMENOPAUSAL WOMEN WITH HYPERPARATHYROIDISM [J].
MARCUS, R ;
MADVIG, P ;
CRIM, M ;
PONT, A ;
KOSEK, J .
ANNALS OF INTERNAL MEDICINE, 1984, 100 (05) :633-640
[20]  
MONCHIK JM, 1992, SURGERY, V112, P1103